Company profile
CannAmerica Brands Corp.
OTC: CNNXF · Healthcare · Medical - Pharmaceuticals
Canadian filerHQ Vancouver, BCReports USD
#979 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ —GM —SS 31
v0.1 · 5/100 weight · pillars only
↑ workforce scale, Piotroski F · ↓ market scale, return on assets
Methodology →Revenue TTM
$408.4k
Rev growth YoY (TTM)
+33.6%
Net income (FY)
-$2.7M
Employees
65
as of 2026-07-12
Market cap
$704
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$292.3k386.5k CAD2020
Net income-$2.7M-3.6M CAD2020
Operating income-$744.8k-984.8k CAD2020
Total assets$242.9k305.4k CAD2020
Liabilities$4.0M5.1M CAD2020
Equity-$3.8M-4.8M CAD2020
Revenue trend
FY2018 – FY2020 · USD
FY18
FY19
FY20
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is CannAmerica Brands Corp.’s revenue?
CannAmerica Brands Corp. booked $292.3k in FY2020 revenue, contracting 39% year over year — slower than 79% of Healthcare companies we track, at a -918.8% net margin.
Peers · Healthcare
ABVC BioPharma, Inc.41DTempest Therapeutics, Inc.24DMotus GI Holdings, Inc.——Hydrogen Hybrid Technologies, Inc.——Aion Therapeutic Inc.——Abattis Bioceuticals Corp.——Key facts
CEOChristophe Cerisey
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersVancouver, BC
ExchangeOTC: CNNXF
Employees65
IPO date2018-12-27
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.